Skip to main content

Table 1 Study measures and timing

From: Protocol for the OUTREACH trial: a randomised trial comparing delivery of cancer systemic therapy in three different settings - patient's home, GP surgery and hospital day unit

  Data point 1: Baseline, prior to commencing treatment Data point 2: 4** weeks into treatment Data point 3: 8** weeks into treatment Data point 4: 12 weeks into treatment Data point 5: 24*** weeks into treatment
Clinic Review* x    x X
PS x x x x X
Weight x x x x  
Blood tests* x     
Radiology* x     
EORTC QLQC30. x x x x X
HAD, EQ-5D and Patient Satisfaction Questionnaire x x x x X
CSRI Completion x    x  
Patient Diary for AE Recording x x x x X
Semi-Structured Interview x(1 in 10 patients)    x  
  1. *Clinic review, blood tests and radiological investigations will be carried out according to standard clinical practice at baseline and during the study period.
  2. ** +/- 1 Week
  3. *** For patients whose treatment continues beyond 12 weeks, patients will complete a further set of trial assessments when their treatment stops or at 24 weeks, whichever is sooner. This data point is optional.